Ideal or Minisiston-Fe composing of low doses of ethynyl estradiol (EE) and levonorgestrel (LNG) was widely used in 61 provinces and cities. This study assessed some demographic aspects of this female contraception, evaluated its effects and side effects on the reproductive-age women (15-49 years old), and identified the factors influencing on the choice of this therapy. 74% of the current users expressed their acceptance, while 27.6% of the subjects, who had ever used this therapy, had no satisfaction.
Pharmaceutical Preparations ; Contraception ; women

HIV/AIDS infection now is increasing and has not been stabilized yet. All 61 out of 61 provinces have HIV/AIDS infected persons. HIV/AIDS is spreading to low risk groups such as recruits and pregnant women. HIV incidence is dramatically increasing in pregnant women from three regions. Pregnant women with HIV infection are important source of transmission in community and should be controlled actively. Pregnant women should be screened for HIV infection and the Gyn-Obs facilities should have relevant instruments to avoid transmission
HIV ; Acquired Immunodeficiency Syndrome

This reseach was conducted in 4 mountainous communes inluding a Pako minority commune and a Van Kieu minority commune and 2 other communes of Kinh in Qu¶ng TrÞ province. 326 married women were randomly selected for attending and interview and examination. A cross-sectional survey was employed and both clinical and laboratory tests was utilized during data collection process. It was explored that 63.80% of the sample were suffering from RTIs. In addition, geographical, ethnic, educational level factors, age and time in marriage, abortion and some reproductive hygiene habits effected on the RTIs prevalence.
Infection ; Women

Ultrasound (US) is currently contributing to early detection of congenital birth defects (CBDs) but its diagnostic value is not yet systemically assessed. Objectives: To describe the distribution of CBDs among children born at the National Hospital of Obstetrics and Gynecology from 2001 to 2003 and to assess the effectiveness and diagnostic value of US. Methods: A descriptive cross-sectional study involving all mothers and their fetuses/newborns with CBDs at the NHOG from Jan 2001 to Dec 2003. Results: The number of fetuses with CBDs detected during the 3 years was 933, accounted for 2.7%. CBDs of the central nervous system and the head-face-neck area accounted for 36.2%; followed by abdominal organs (33.0%), bones and extremities (17.0%), thorax (9.0%) and others. The percentage of CBDs detected at gestational age from 12 to 23 weeks has increased two-fold from 2001 to 2003. Conclusions: The percentage of CBDs detected during the 3 years was 2.7%, with CBDs of the central nervous system and the head-face-neck area accounted for 36.2%; followed by abdominal organs (33.0%), bones and extremities (17.0%), thorax (9.0%). US played the 1st role leading to suspicion of CBDs (39.7%). For fetuses less than 32 weeks, 2-D and 3-D US have diagnostic values of more than 97%.
Congenital Abnormalities ; Early Diagnosis ; Diagnosis

A prospective study was performed on 72 endometrial hyperplasia patients who had been treated by progestin from 2000 - 2004. Results: After 3-6 months of the treatment, there were 57 patients recovered completely (79.16%); 10 patients had hysterectomy because of unsuccessful treatment, these patients had uterus polyp, leiomyoma, long bleeding unrespond to treatment; 1 case was defined endometrial cancer afterward. 3 patients had endometrial hyperplasia in endometrial biopsy after 6 months of intensive treatment. Using of progestin in treating endometrial hyperplasia needs an accurate pathological diagnosis of endometrial diseases, the cooperation of doctors and a regular follow- up. Women with endometrial hyperplasia who were treated with progestin had uterus preserved therefore their menstruation became regularly after recovering and; several young women even got pregnant and become a mother.
Endometrial Hyperplasia ; Therapeutics

Surgical sperm retrieval (SSR) is currently one of the most common procedures in in vitro fertilization (IVF). However, a gap between the guidelines and routine clinical practice regarding antibiotic use in SSR, which might lead to antibiotic resistance, is a challenging problem worldwide. A cross-sectional survey was conducted from May 1, 2021, to July 15, 2021, to investigate antibiotic usage by medical professionals when performing SSR in IVF centers in Vietnam. The confidential questionnaire comprised 12 items, including characteristics of the study population, awareness of antimicrobial resistance, attitude toward prescribing antibiotics, and current practice of prescribing antibiotics when performing SSR. Surveys were completed by 30 of 45 registered IVF centers (66.7%). Among 67 physicians working at those centers, the age and work-experience years (mean ± standard deviation [s.d.]) were 38.6 ± 6.6 years and 11.2 ± 7.0 years, respectively. Over 60% of them held a degree in Obstetrics and Gynecology, and over four-fifths were men. Most respondents "often/very often/always" raised awareness of antimicrobial resistance to their patients (83.3%), but only half of them "often/occasionally" prescribed antibiotics to patients with SSR in cases where the prescription would be optional. About one-tenth of respondents followed the recommendation from the American Urological Association using "prophylaxis only" for SSR patients. For more invasive SSR, physicians tended to prescribe more complicated and sometimes inappropriate regimens. In conclusion, antibiotic usage in SSR was not always appropriate among IVF centers. Further studies may define specific recommendations for regimens, intervention strategies, and programs to promote appropriate antibiotic use for SSR patients among IVF specialists.
Humans ; Male ; Female ; Anti-Bacterial Agents/therapeutic use* ; Sperm Retrieval ; Cross-Sectional Studies ; Semen ; Surveys and Questionnaires ; Fertilization in Vitro ; Practice Patterns, Physicians'